Unified clinical trial software
Unified clinical trial software for food industry trials
oomnia connects workflows for food studies, helping teams manage dietary data, study design, and real‑world consumption with greater efficiency and control
INDUSTRY CONTEXT
Why food industry trials are hard to run
Food and nutrition studies introduce unique operational challenges, driven by variability in human behavior, dietary patterns, and real‑world consumption environments. Unlike highly controlled clinical trials, food studies often depend on self‑reported data and long‑term lifestyle factors.
Key execution challenges include:
High variability in diet, lifestyle, and participant adherence
Dependence on self‑reported consumption and patient‑reported outcomes
Difficulty standardizing endpoints across nutritional and functional outcomes
Fragmented data from wearables, apps, labs, and questionnaires
Challenges in tracking long‑term dietary effects and health outcomes
Complex coordination across research sites, home settings, and digital tools
UNIFIED PLATFORM
Why unified clinical trial software matters for food industry trials
Food and nutrition studies often rely on separate systems for dietary tracking, clinical data, lab analysis, and participant engagement. This fragmentation creates inefficiencies, increases the risk of data gaps, and makes it harder to generate reliable insights.
A unified clinical trial platform, built as a Clinical Research Information System (CRIS), connects all food industry study components within one environment.
This enables continuous data flow, improved consistency, and real‑time visibility across food and nutrition trials.
| Area | Modular eClinical system | Unified clinical trial software (oomnia) |
|---|---|---|
| Data types | Dietary, clinical, and digital data in separate systems | All study data unified in one system |
| Data consistency | Variability from self‑reported and device data | Standardized data structures across studies |
| Reconciliation | Manual alignment of diet, lab, and outcome data | Reduced reconciliation through shared model |
| Monitoring | Limited visibility into adherence and outcomes | Real‑time tracking of participant data |
| Execution | Disconnected workflows across tools and teams | Unified workflows across all stakeholders |
| Data quality | Higher risk of missing or inconsistent data | Structured capture with validation checks |
| Oversight | Fragmented view across study components | Centralized, real‑time oversight |
| Scalability | Difficult to scale large nutrition programs | Scalable across regions and study designs |
CRIS ARCHITECTURE
One unified clinical trial platform for food industry trials
oomnia unifies core study functions into a single Clinical Research Information System (CRIS), designed to support the complexity of food, nutrition, and consumer health research
Handles diverse data sources, including diet tracking, clinical data, and digital inputs
Shared data model aligns clinical, behavioral, and observational data
Flexible configuration enables protocol adjustments without disrupting studies
Replaces disconnected tools with one integrated workflow
ECOSYSTEM INTEGRATION
How oomnia fits in the food industry research ecosystem
oomnia serves as a central hub connecting stakeholders and systems involved in food and nutrition studies
It integrates:
KEY CAPABILITIES
Key capabilities for food industry trials
Flexible study design for dietary interventions
- Supports a wide range of study designs, including controlled feeding studies, observational trials, and long‑term nutrition programs
- Adapts to protocol changes such as dietary interventions, visit schedules, or outcome measures
- Maintains consistency across sites and participants during in‑study modifications
Data capture and quality
- Enables real‑time capture of dietary intake, clinical measurements, lab results, and digital health data
- Unifies EDC, CTMS, RTSM, ePRO/eCOA, eTMF, eSource, and eConsent in one system
- Reduces manual reconciliation across diet tracking tools, labs, and clinical data sources
Tracking participant behavior and dietary adherence
- Supports remote and hybrid study models, including home‑based data collection
- Captures patient‑reported outcomes, dietary logs, and device‑generated data
- Uses reminders and structured workflows to improve adherence and data completeness
Real‑time visibility across food study data
- Provides centralized dashboards across participants, sites, and study phases
- Supports monitoring of adherence, safety signals, and study progress
- Delivers structured datasets for analysis and regulatory or scientific reporting
Nutrition biomarkers and lab data integration
- Integrates metabolic, nutritional, and biomarker data from central labs
- Links dietary intake with clinical and biological outcomes
- Enables a comprehensive view of nutrition‑related effects across studies
Designed for real‑world nutrition and consumer health research
Unified architecture removes fragmentation across dietary, clinical, and digital data
Flexible configuration supports evolving study designs and endpoints
Simplifies workflows across sites, participants, and research partners
VALUE PROPOSITION
Why sponsors choose oomnia for food industry trials
Client Testimonials
Collaboration built on trust and innovation
Wemedoo's technology, expertise, and intimate engagement with our team in the development of the EDC, site/patient interface, and metric capabilities are unique. They provided insight and challenged the underlying assumptions to ensure the study's goals and objectives were clearly defined and the operating structure matched with the study's intent. Their system is not a one-size-fits-all and they adapt to the needs of the sponsor, sites, physicians, and the study requirements into a system that merges health information/data and can then become not only informative but actionable.
James Kuras
Vice President of Clinical Affairs and Operations at Centinel Spine
Wemedoo's cross-functional, integrated teams capture EDC set-up, go-live, data capture, data cleaning, and finally data analysis in a globally compliant fashion supporting trials in different geographies including the US. Their speed of addressing customer needs sets in my personal experience industry benchmark whilst keeping these data solutions lean and affordable. Besides the great proprietary systems they use, their integrated team approach with personal responsibility and honest commitment to targeting outcomes differentiates the Wemedoo team from other providers. Wemedoo only made Oxular's key initial trial, a device-drug trial possible, as based on some pre-work, the Wemedoo team could substantially adapt and update the first EDC ideas for a trial under a US FDA IND. The Wemedoo team worked extremely focused on familiarizing US trial sites and clinical CROs with the use of their system, which turned out to be a key success factor of the respective trial. The highly professional and up-to-date capabilities in data sciences were mirrored by customer-centricity and super fast timelines of integrating mandatory adaptations to the data systems.
Friedrich Asmus
Former Chief Medical Officer at OXULAR
All jobs, both large and small, are performed with the same dedication to quality, detail, innovative thinking, and rigor. It is always a pleasure to work with the Wemedoo team.
Georg Mathis, PhD
CEO at Appletree CI Group AG
Wemedoo embodies all the traits desired in a partner in the clinical trial industry – expertise, innovation, reliability, compliance, and attention to detail.
Martina Diminic Smetisko, DMD
Managing Director at Marti Farm Ltd
Their dedication to, and support of, our projects has resulted in clear quality deliverables. They are always there to answer any questions with expertise in a timely manner. I am looking forward to our next project together.
Volodymyr Stus, MD
Biopharmaceutics and Clinical Research Department Manager at Polpharma SA
Complex adaptive trials demand speed, precision, and system stability. With oomnia, Wemedoo's unified clinical trial software maintained continuous drug supply oversight, real-time data capture above 99%, and zero Randomization and Trial Supply Management (RTSM) dispensing errors throughout the study. The study reached database lock within 3 days after Last Patient Last Visit (LPLV), a direct result of integrated EDC–RTSM execution and proactive technical support. Wemedoo's technology and team responsiveness played a key role in meeting aggressive milestones.
Dhiraj Patel, Dr.
Director at Velocious Clinical Research
REGULATORY READINESS
Compliance and data environment readiness
oomnia provides a compliance‑aligned environment suited to food and nutrition research programs
21 CFR Part 11–compliant records
21 CFR Part 11–compliant electronic records with full audit trails for inspection-ready documentation
ICH E6(R3)–aligned oversight
ICH E6(R3)‑aligned risk‑based oversight where applicable to food and nutrition study contexts
CDISC-aligned data structures
CDISC‑aligned data structures for standardized reporting and submission-ready outputs
Global regulatory submissions
Support for global regulatory and scientific submissions across regions and study types
Get Started
Run food and nutrition studies with greater efficiency
Connect diet tracking, clinical data, and real‑world inputs to improve visibility and strengthen food study results
Talk to our team